Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Patents
Studies from University of Ulm, Department of Psychiatry have provided new information about patents
January 29th, 2007
Investigators publish new data in the report "The origin of MDMA (ecstasy) revisited: the true story reconstructed from the original documents." According to recent research from Ulm, Germany, "Little is known about the origin of methylenedioxymethamphetamine (MDMA, ecstasy). The most commonly repeated statement in the medical literature is that MDMA was synthesized by the German pharmaceutical company Merck in 1912 in order to develop an appetite suppressor." "To reconstruct the true story of the first known description of MDMA at Merck using the original documents. A systematic analysis of the original documents in Merck's historical archive in Darmstadt, Germany, was...
Source: Biotech Business Week (2007-01-29)
|
